Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 7
BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
Authors Larsen S, Butthongkomvong K , Manikhas A, Lindkær-Jensen S, Trishkina E, Poddubudkaya E, Matrosova M, Srimuninnimit V
Received 18 March 2015
Accepted for publication 18 March 2015
Published 29 June 2015 Volume 2015:7 Pages 163—164
Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.
On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group.
Read the original article
© 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.